Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Jazz Pharmaceuticals plc
Feb 26, 2019
Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2018 Financial Results
Feb 14, 2019
Jazz Pharmaceuticals Announces Appointment of Anne O'Riordan to its Board of Directors
Feb 12, 2019
Jazz Pharmaceuticals to Report 2018 Fourth Quarter and Full Year Financial Results on February 26, 2019
Dec 21, 2018
Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Dec 19, 2018
Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 7
Dec 10, 2018
Jazz Pharmaceuticals Announces Share Repurchase Program Authorization Increase of $400 Million
Nov 29, 2018
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
Nov 28, 2018
Jazz Pharmaceuticals to Highlight Hematology Research at ASH 2018 Annual Meeting
Nov 07, 2018
Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Nov 07, 2018
National Institute for Health and Care Excellence (NICE) Recommends Jazz Pharmaceuticals' Vyxeos® (Daunorubicin and Cytarabine) for Adults with Specific Types of Secondary Acute Myeloid Leukaemia (AML)
Oct 29, 2018
Jazz Pharmaceuticals Announces FDA Approval of Xyrem® (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients
Oct 23, 2018
Jazz Pharmaceuticals to Report 2018 Third Quarter Financial Results on November 6, 2018
Sep 11, 2018
Jazz Pharmaceuticals Announces an Informational Webcast for Investors Related to Vyxeos EU Launch
Aug 29, 2018
Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences
Aug 27, 2018
Vyxeos® Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia
Aug 07, 2018
Jazz Pharmaceuticals Announces Second Quarter 2018 Financial Results
Aug 06, 2018
Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic Malignancies
Jul 24, 2018
Jazz Pharmaceuticals to Report 2018 Second Quarter Financial Results on August 7, 2018
Jul 19, 2018
Journal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos® (daunorubicin and cytarabine) Liposome for Injection
Jun 29, 2018
Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt
‹‹
Page 4
››
Latest News
Apr 25, 2024
"World's Greatest Aviation Celebration" returns July 22-28
Apr 25, 2024
Balboa Geo to Present its POINTER Technology at the U.S. DEPARTMENT of HOMELAND SECURITY OpEx Event in Las...
Apr 25, 2024
Bureau Veritas: Strong Start to the Year; 2024 Outlook Confirmed
Apr 25, 2024
AprilAire® Professional-Grade Smart Thermostat Now ENERGY STAR® Certified
Apr 25, 2024
Luxury Apartments in Double Bay, Australia, Built for Durability with Penetron Technology
Apr 25, 2024
RTX breaks ground on $115 million expansion of Alabama missile integration facility
Apr 25, 2024
Tactical communications for the Bundeswehr: Rheinmetall wins framework contract with a potential order value...
Apr 25, 2024
GE Aerospace LM2500 Gas Turbine-Powered USCGC Calhoun Commissioned by United States Coast Guard
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events